Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Glycopyrrolate; Neostigmine Methylsulfate Patent Expiration

Glycopyrrolate; Neostigmine Methylsulfate was first introduced by Azurity Pharmaceuticals Inc in its drug Prevduo on Feb 23, 2023.


Glycopyrrolate; Neostigmine Methylsulfate Patents

Given below is the list of patents protecting Glycopyrrolate; Neostigmine Methylsulfate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Prevduo US10456354 Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate Oct 25, 2038 Azurity
Prevduo US11110054 Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate Oct 25, 2038 Azurity
Prevduo US11938217 Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate Oct 25, 2038 Azurity


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳